Answers are grounded in this paper and cite their sources.
Retrospective analysis shows decreased pain medication use in adults receiving selumetinib, suggesting potential pain management benefits.
This retrospective claims analysis assessed the impact of selumetinib on prescription pain medication utilization (PPMU) in adults over a 3-year period.
No takes yet. Share an insight, caveat, or question.
Lyons et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: